Clinical Trials Directory

Trials / Unknown

UnknownNCT03579862

Identification of Heritable CTEPH

Identification and Molecular Characterization of Heritable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Status
Unknown
Phase
Study type
Observational
Enrollment
260 (estimated)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Some patients who have blood clots come down with a life-threatening condition known as Chronic Thromboembolic Pulmonary Hypertension (CTEPH), which is high blood pressure only in the arteries of the lungs. This study seeks to understand more about the genetics causes of CTEPH by obtaining blood samples and examining family histories.

Detailed description

This project proposes to identify a cohort of Utah patients with CTEPH, and to perform a comprehensive analysis of family history and CTEPH risk factors in these patients, and in controls with acute pulmonary embolism (PE) and pulmonary arterial hypertension (PAH). Detailed family history interviews will be performed with all patients, and all enrolled patients will provide a blood sample for thrombophilia testing and for gene sequencing with the goal of identifying novel genetic variants that contribute to CTEPH risk.

Conditions

Interventions

TypeNameDescription
OTHERBlood Draw

Timeline

Start date
2013-12-25
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2018-07-09
Last updated
2022-10-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03579862. Inclusion in this directory is not an endorsement.